InsidersTradesSigma
Total declarations
Company
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
6
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-15.0%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Cyrille Tupin, Chief Executive Officer. Officer active across 1 company, notably Abionyx Pharma. Aggregated, 7 filings have been logged. Breakdown: 6 buys · 0 sell. Total volume traded: €9k. Activity tracked since 3 December 2021. The latest transaction was disclosed on 28 February 2023 (Acquisition d'actions gratuites de performance). Regulator: AMF. All data is accessible without signup.
Companies and markets linked to Cyrille Tupin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
523,965 shares0ActionEuronext ParisISIN FR00126168522026DD1135500
Canonical exit: 22 Nov 2026 (T+90)
523,965 shares0ActionEuronext ParisISIN FR00126168522026DD1135094
Canonical exit: 22 Nov 2026 (T+90)
53,913 shares0ActionEuronext ParisISIN FR00126168522023DD887173
Canonical exit: 29 May 2023 (T+90)
187,500 shares0ActionEuronext ParisISIN FR00126168522022DD872734
Canonical exit: 16 Feb 2023 (T+90)
5,300 shares@ €1.793.7% of flowActionEuronext ParisISIN FR00126168522022DD826422
Canonical exit: 9 Jun 2022 (T+90)
438,940 shares0ActionEuronext ParisISIN FR00126168522021DD812033
Canonical exit: 10 Mar 2022 (T+90)
69,444 shares@ €3.6096.3% of flowActionEuronext ParisISIN FR00126168522021DD811860
7 of 7 declarations
About Cyrille Tupin
Cyrille Tupin is Directeur Général d’ABIONYX Pharma. He has 6 filings in total, all on Abionyx Pharma, and the 6 sampled filings run from 2021-12-10 to 2026-08-27, with EUR 259485 of purchases and EUR 0 of sales over that recent sample. The most frequent transaction nature indicated is Acquisition d'actions gratuites de performance.
